Regis Healthcare's revenue for the
six
months ended in Dec. 2025 was A$173 Mil.
Its revenue for the trailing twelve months (TTM) ended in Dec. 2025 was A$1,191 Mil.
Regis Healthcare's Revenue per Share for the
six
months ended in Dec. 2025 was A$0.57.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$3.89.
Warning Sign:
Regis Healthcare Ltd revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Regis Healthcare was 13.70% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 76.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 47.20% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 20.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 11 years, Regis Healthcare's highest 3-Year average Revenue per Share Growth Rate was 76.90% per year. The lowest was 2.20% per year. And the median was 8.25% per year.
Regis Healthcare (ASX:REG) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Regis Healthcare Revenue Related Terms
Regis Healthcare Revenue Historical Data
* Premium members only.
The historical data trend for Regis Healthcare's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Regis Healthcare's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Regis Healthcare Revenue vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Regis Healthcare's Revenue distribution charts can be found below:
* The bar in red indicates where Regis Healthcare's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$1,191 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Regis Healthcare (ASX:REG) has a Revenue of A$1,191 Mil as of Dec. 2025. Revenue is the total amount a company generates as sales through its operations. View historical data on Regis Healthcare and its competitors.
Is Regis Healthcare's Revenue too high?
Regis Healthcare's current Revenue is A$1,191 Mil. Overall, Regis Healthcare has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Regis Healthcare's Revenue compare to HCA and THC?
Regis Healthcare's Revenue of A$1,191 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Regis Healthcare and its competitors. Regis Healthcare's current Revenue is A$1,191 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regis Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Regis Healthcare (ASX:REG) is currently considered Possible Value Trap. The stock's GF Value™ is A$10.53, compared to a current price of A$6.47 — trading 38.6% below its estimated fair value. The current Revenue is A$1,191 Mil. Regis Healthcare's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Regis Healthcare (ASX:REG), the current Revenue is A$1,191 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Regis Healthcare (ASX:REG) Overvalued in 2026?
Based on GuruFocus' analysis, Regis Healthcare stock appears to be undervalued.
The current stock price of A$6.47 is trading 38.6% below its estimated GF Value™ of A$10.53.
GuruFocus considers Regis Healthcare to be Possible Value Trap.
Key valuation signals for ASX:REG:
Revenue: A$1,191 Mil
GF Value™: A$10.53 vs. price of A$6.47 (38.6% below fair value)
No single metric tells the full story. See the ASX:REG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Regis Healthcare is an Australian residential aged care operator providing accommodation and care for individuals who require high levels of support due to health or mobility issues. Residents are typically over 85 years old and are typified by dementia, palliative care, incontinence, and falls risk. Regis also operates smaller retirement village and home care businesses.
84GF Score
Get the complete analysis for ASX:REG
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:REG has been successfully added to your 
